{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00901",
      "entity_text" : "anti-ScFvEGFR antibody",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:10090" ],
      "TissueType" : [ "tissuelist:TS-0923" ]
    }
  },
  "verbose_text" : "ELISA assay showed that the level of anti-ScFvEGFR antibody in the serum samples collected from the Balb/c mouse treated with ScFvEGFR-PEG-IONPs was 25-fold higher than that in the serum sample of SCID mouse treated with the same nanoparticles (serum dilution, 1:5000, Figure XREF_FIG C).",
  "reading_complete" : "2020-08-02T08:15:54Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T08:13:38Z",
  "trigger" : "level",
  "evidence" : [ "level of anti-ScFvEGFR antibody" ],
  "pmc_id" : "4265747",
  "score" : 0
}